The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation
Main Authors: | Grozinsky-Glasberg, S, Rubinfeld, H, Cohen, O, Greif, F, Kammer, A, Grossman, AB, Shimon, I |
---|---|
Format: | Conference item |
Published: |
2011
|
Similar Items
-
Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
by: Liu, Qingsong, et al.
Published: (2015) -
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
by: Grozinsky-Glasberg, S, et al.
Published: (2008) -
Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
by: Druce, MR, et al.
Published: (2009) -
The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
by: Grozinsky-Glasberg, S, et al.
Published: (2009) -
mTORC inhibitors as broad-spectrum therapeutics for age-related diseases
by: Walters, H, et al.
Published: (2018)